1. Home
  2. APLS vs HUN Comparison

APLS vs HUN Comparison

Compare APLS & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$20.64

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$12.36

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
APLS
HUN
Founded
2009
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.3B
IPO Year
2015
2004

Fundamental Metrics

Financial Performance
Metric
APLS
HUN
Price
$20.64
$12.36
Analyst Decision
Buy
Hold
Analyst Count
20
11
Target Price
$31.79
$12.09
AVG Volume (30 Days)
1.9M
6.8M
Earning Date
04-02-2026
05-20-2026
Dividend Yield
N/A
2.77%
EPS Growth
112.50
N/A
EPS
0.20
N/A
Revenue
$1,003,782,000.00
$5,683,000,000.00
Revenue This Year
N/A
$4.01
Revenue Next Year
$17.57
$5.14
P/E Ratio
$103.98
N/A
Revenue Growth
28.46
N/A
52 Week Low
$16.10
$7.30
52 Week High
$30.48
$18.08

Technical Indicators

Market Signals
Indicator
APLS
HUN
Relative Strength Index (RSI) 38.18 49.22
Support Level $18.95 $10.76
Resistance Level $24.37 $14.38
Average True Range (ATR) 0.97 0.85
MACD -0.14 -0.17
Stochastic Oscillator 20.13 26.42

Price Performance

Historical Comparison
APLS
HUN

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Share on Social Networks: